Drug Type Small molecule drug |
Synonyms Inarigivir soproxil/tenofovir disoproxil fumarate, SB 9200/tenofovir disoproxil fumarate + [3] |
Target |
Mechanism NOD2 antagonists(Nucleotide-binding oligomerization domain-containing protein 2 antagonists), RIG-I stimulants(Retinoic acid-inducible gene I stimulants), RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H34N7O13PS |
InChIKeyCJCYTUJOSMYXLE-JDLSZIHUSA-N |
CAS Registry942123-43-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Phase 2 | - | - |